EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

RELEVANT LEGISLATION
Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list

Stranica 63 od 97
50 Broj stavki po stranici
Prikazano 3.101 - 3.150 od 4.821 rezultata.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU_BA Directive 2000/54/EC
EU REACH: List of SVHC
mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt
616-995-5
8018-01-7
Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1
maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)
235-654-8
12427-38-2
Repr. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
manganese dioxide
215-202-6
1313-13-9
Acute Tox. 4
manganese sulphate
232-089-9
7785-87-7
STOT RE 2
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]
239-924-6
15825-70-4
Unst. Expl.
mannitol hexanitrate; nitromannite;mannitol hexanitrate; nitromannite;[>40 % phlegmatiser]
239-924-6
15825-70-4
Expl. 1.1
Mansonella ozzardi
-
-
P Parasites
Mansonella perstans
-
-
P Parasites
Marburg virus
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Mayaro virus
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
MCPA (ISO); 4-chloro-o-tolyloxyacetic acid
202-360-6
94-74-6
Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate
246-831-4
25319-90-8
Acute Tox. 4
Measles virus
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O, O-diethyl phosphorodithioate
219-993-9
2595-54-2
Acute Tox. 3
mecetronium etilsulfate; N-ethyl-N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate; [MES]
221-106-5
3006-10-8
Skin Corr. 1; Eye Dam. 1
mecoprop-P (ISO) [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy) propionic acid [1] and its salts
240-539-0
16484-77-8
Acute Tox. 4; Eye Dam. 1
mecoprop-P (ISO) [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy) propionic acid [1] and its salts
show/hide
mecoprop-P (ISO); (R)-2-(4-chloro-2-methylphenoxy)propionic acid EC / List no: 240-539-0 | CAS no: 16484-77-8
-
-
Acute Tox. 4; Eye Dam. 1
mecrilate; methyl 2-cyanoacrylate
205-275-2
137-05-3
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-6
2487-01-6
Acute Tox. 3; Acute Tox. 4
menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonicacid, compound with nicotin-3-amide (1:1)
277-543-7
73581-79-0
Eye Irrit. 2; Skin Irrit. 2
menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt
204-987-0
130-37-0
Eye Irrit. 2; Skin Irrit. 2
menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate
201-123-4
78-57-9
Acute Tox. 4
mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine
432-140-7
110235-47-7
Carc. 2
mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3
950-10-7
Acute Tox. 1; Acute Tox. 2
mequinol; 4-methoxyphenol; hydroquinone monomethyl ether
205-769-8
150-76-5
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-2
2032-65-7
Acute Tox. 3
mercury
231-106-7
7439-97-6
Repr. 1B; Acute Tox. 2; STOT RE 1
mercury dichloride; mercuric chloride
231-299-8
7487-94-7
Muta. 2; Repr. 2; Acute Tox. 2; STOT RE 1; Skin Corr. 1B
mercury difulminate; mercuric fulminate; fulminate of mercury;mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser]
211-057-8
628-86-4
Unst. Expl.; Acute Tox. 3; STOT RE 2
mercury difulminate; mercuric fulminate; fulminate of mercury;mercury difulminate; mercuric fulminate; fulminate of mercury [≥ 20 % phlegmatiser]
211-057-8
628-86-4
Expl. 1.1; Acute Tox. 3; STOT RE 2
mesitylene; 1,3,5-trimethylbenzene
203-604-4
108-67-8
Flam. Liq. 3; STOT SE 3
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
600-533-4
104206-82-8
Repr. 2; STOT RE 2
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]; [1] (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]
604-167-6
139968-49-3
Repr. 2; Lact.; STOT RE 2
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]; [1] (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]
701-454-9
852403-68-0
Repr. 2; Lact.; STOT RE 2
metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex
-
-
Acute Tox. 4
metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-7
57837-19-1
Acute Tox. 4; Skin Sens. 1
metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
615-135-6
70630-17-0
Acute Tox. 4; Eye Dam. 1
metam-sodium (ISO); sodium methyldithiocarbamate
205-293-0
137-42-8
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-3
41394-05-2
Acute Tox. 4
metazachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-acetamide
266-583-0
67129-08-2
Skin Sens. 1B; Carc. 2
metconazole (ISO); (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
603-031-3
125116-23-6
Repr. 2; Acute Tox. 4
methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate
630-448-8
62610-77-9
Acute Tox. 4; Skin Sens. 1
methacrylic acid; 2-methylpropenoic acid
201-204-4
79-41-4
Acute Tox. 4; Skin Corr. 1A
methacrylonitrile; 2-methyl-2-propene nitrile
204-817-5
126-98-7
Flam. Liq. 2; Acute Tox. 3; Skin Sens. 1
methamidophos (ISO); O,S-dimethyl phosphoramidothioate
233-606-0
10265-92-6
Acute Tox. 2; Acute Tox. 3
methane
200-812-7
74-82-8
Flam. Gas 1; Press. Gas
methanesulphonic acid
200-898-6
75-75-2
Skin Corr. 1B
methanethiol; methyl mercaptan
200-822-1
74-93-1
Flam. Gas 1; Press. Gas; Acute Tox. 3
methanol
200-659-6
67-56-1
Flam. Liq. 2; Acute Tox. 3; STOT SE 1
methenamine; hexamethylenetetramine
202-905-8
100-97-0
Flam. Sol. 2; Skin Sens. 1
Stranica 63 od 97
50 Broj stavki po stranici
Prikazano 3.101 - 3.150 od 4.821 rezultata.

Export search results to: